{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:40:51Z","timestamp":1795041651721,"version":"4.10.2"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2024,7,15]]},"abstract":"<jats:p>In oncologic patients, optimal postoperative wound healing is crucial for the maintenance of systemic therapies and improved survival. Although several risk factors for postoperative wound complications have been identified, the clinical effect of new antineoplastic agents on wound healing remains uncertain. The available literature on the effect of antineoplastic agents in wound healing is complex to analyze because of other confounding risk factors such as radiation therapy and certain patient-specific variables. Available perioperative drug recommendations are based on database opinion and case reports from adverse event alerts. This review highlights the characteristics of old and new antineoplastic agents commonly used in the treatment of sarcoma, carcinoma, and other cancers and their potential effects on the wound-healing process. It also aims to provide perioperative treatment cessation recommendations to guide orthopaedic surgeons and prevent drug-related wound complications to the fullest extent possible.<\/jats:p>","DOI":"10.5435\/jaaos-d-24-00097","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T14:00:33Z","timestamp":1715090433000},"page":"e671-e682","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Wound-Healing Effects of Common Antineoplastic Agents and Perioperative Considerations for the Orthopaedic Surgeon"],"prefix":"10.5435","volume":"32","author":[{"given":"Erhan","family":"Okay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos R.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0681-9004","authenticated-orcid":false,"given":"Santiago A.","family":"Lozano-Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/502033","article-title":"The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: Adverse quality of life, excess length of stay, and extra cost","volume":"23","author":"Whitehouse","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.suronc.2020.02.016","article-title":"Wound complications are a predictor of worse oncologic outcome in extremity soft tissue sarcomas","volume":"33","author":"Dadras","year":"2020","journal-title":"Surg Oncol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"m4087","DOI":"10.1136\/bmj.m4087","article-title":"Mortality due to cancer treatment delay: Systematic review and meta-analysis","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jso.27205","article-title":"Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the children's oncology group and NRG oncology","volume":"127","author":"Kayton","year":"2023","journal-title":"J Surg Oncol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.bjps.2019.05.041","article-title":"Risk factors for postoperative wound complications after extremity soft tissue sarcoma resection: A systematic review and meta-analyses","volume":"72","author":"Slump","year":"2019","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jtv.2020.10.004","article-title":"Methotrexate reduces keratinocyte proliferation, migration and induces apoptosis in HaCaT keratinocytes in vitro and reduces wound closure in Skh1 mice in vivo","volume":"30","author":"Medell\u00edn-Luna","year":"2021","journal-title":"J Tissue Viability"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/14740338.2017.1310839","article-title":"Effect of methotrexate on bone and wound healing","volume":"16","author":"Pountos","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"831616","DOI":"10.1155\/2012\/831616","article-title":"Gemcitabine-induced extensive skin necrosis","volume":"2012","author":"D'Epiro","year":"2012","journal-title":"Case Rep Med"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.freeradbiomed.2006.03.027","article-title":"Adriamycin promotes macrophage dysfunction in mice","volume":"41","author":"Asmis","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00595-004-2865-7","article-title":"Optimal timing for surgery after adriamycin treatment in rats","volume":"34","author":"Gulcelik","year":"2004","journal-title":"Surg Today"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0936-6555(05)80771-X","article-title":"Intra-arterial adriamycin, conventionally fractionated radiotherapy and conservative surgery for soft tissue sarcomas","volume":"4","author":"Mason","year":"1992","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"bcr2016218012","DOI":"10.1136\/bcr-2016-218012","article-title":"Epirubicin extravasation: Consequences of delayed management","volume":"2017","author":"Hale","year":"2017","journal-title":"BMJ Case Rep"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.3390\/cancers12113408","article-title":"Continuous 14 day infusional ifosfamide for management of soft-tissue and bone sarcoma: A single centre retrospective cohort analysis","volume":"12","author":"Carter","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00006534-196009000-00005","article-title":"The effects of cytoxan (cyclophosphamide) on wound healing","volume":"26","author":"Desprez","year":"1960","journal-title":"Plast Reconstr Surg Transpl Bull"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5114\/ada.2018.72585","article-title":"Wound healing complications in oncological patients: Perspectives for cellular therapy","volume":"36","author":"Deptu\u0142a","year":"2019","journal-title":"Postepy Dermatol Alergol"},{"key":"R16-20250503","first-page":"487","article-title":"Effect of cyclophosphamide on the course of cutaneous wound healing","volume":"24","author":"Mann","year":"1977","journal-title":"Neoplasma"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/019459988609500214","article-title":"Influence of cisplatin on wound healing--an experimental model","volume":"95","author":"Stiernberg","year":"1986","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/gut.2006.118380","article-title":"Delayed healing of percutaneous endoscopic gastrostomy site during chemotherapy","volume":"56","author":"Garsed","year":"2007","journal-title":"Gut"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0277-5379(86)90389-5","article-title":"Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients","volume":"22","author":"Gouyette","year":"1986","journal-title":"Eur J Cancer Clin Oncol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ijc.29023","article-title":"Antiangiogenic activity of trabectedin in myxoid liposarcoma: Involvement of host TIMP-1 and TIMP-2 and tumor thrombospondin-1","volume":"136","author":"Dossi","year":"2015","journal-title":"Int J Cancer"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1002\/cncr.32462","article-title":"Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin","volume":"125","author":"Jones","year":"2019","journal-title":"Cancer"},{"key":"R22-20250503","first-page":"238","article-title":"Effects of antineoplastic agents on wound healing in mice","volume":"78","author":"Cohen","year":"1975","journal-title":"Surgery"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/SAP.0000000000001519","article-title":"The effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid and paclitaxel treatment on full-thickness wound healing in mice","volume":"81","author":"Marcotte","year":"2018","journal-title":"Ann Plast Surg"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10151-005-0227-0","article-title":"Role of the antiangiogenetic drug paclitaxel on healing of intestinal anastomosis: An experimental study","volume":"9","author":"Y\u00fcceyar","year":"2005","journal-title":"Tech Coloproctol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/wrr.12763","article-title":"Local and transient inhibition of p21 expression ameliorates age-related delayed wound healing","volume":"28","author":"Jiang","year":"2020","journal-title":"Wound Repair Regen"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2353\/ajpath.2006.060196","article-title":"Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing","volume":"169","author":"Rajkumar","year":"2006","journal-title":"Am J Pathol"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/jth.15354","article-title":"Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy","volume":"19","author":"Watson","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.ASW.0000725176.48771.0f","article-title":"Impaired wound healing with imatinib mesylate therapy","volume":"34","author":"Ronicke","year":"2021","journal-title":"Adv Skin Wound Care"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13014-016-0654-2","article-title":"Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: Results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03)","volume":"11","author":"Jakob","year":"2016","journal-title":"Radiat Oncol"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40264-014-0139-x","article-title":"Effect of tyrosine kinase inhibitors on wound healing and tissue repair: Implications for surgery in cancer patients","volume":"37","author":"Shah","year":"2014","journal-title":"Drug Saf"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1177\/1078155218817109","article-title":"Wound healing complications with lenvatinib identified in a pharmacovigilance database","volume":"25","author":"Cheng","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijsu.2005.04.001","article-title":"A review of the surgical management of metastatic gastrointestinal stromal tumours (GISTs) on imatinib mesylate (Glivec)","volume":"3","author":"Barnes","year":"2005","journal-title":"Int J Surg"},{"issue":"suppl 2","key":"R33-20250503","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.seminoncol.2014.01.001","article-title":"Management of sorafenib-related adverse events: A clinician's perspective","volume":"41","author":"Brose","year":"2014","journal-title":"Semin Oncol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.4049\/jimmunol.181.6.3974","article-title":"Defects in skin gamma delta T cell function contribute to delayed wound repair in rapamycin-treated mice","volume":"181","author":"Mills","year":"2008","journal-title":"J Immunol"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000329902","article-title":"Cutaneous and mucosal aphthosis during temsirolimus therapy for advanced renal cell carcinoma: Review of cutaneous and mucosal side effects of mTOR inhibitors","volume":"223","author":"De Masson","year":"2011","journal-title":"Dermatology"},{"key":"R36-20250503","first-page":"e0689","article-title":"Bevacizumab effect on viability of free groin flaps in rats","volume":"38","author":"Mamede","year":"2023","journal-title":"Braz J Plast Sugery"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1470-2045(09)70341-9","article-title":"Vascular endothelial growth factor targeted therapy in the perioperative setting: Implications for patient care","volume":"11","author":"Bose","year":"2010","journal-title":"Lancet Oncol"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hed.26601","article-title":"Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer","volume":"43","author":"Mays","year":"2021","journal-title":"Head Neck"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jamcollsurg.2017.08.023","article-title":"Association between targeted HER-2 therapy and breast reconstruction outcomes: A propensity score-matched analysis","volume":"225","author":"Shammas","year":"2017","journal-title":"J Am Coll Surg"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ajh.25764","article-title":"Treatment and disease-related complications in multiple myeloma: Implications for survivorship","volume":"95","author":"Chakraborty","year":"2020","journal-title":"Am J Hematol"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-24-00097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:47:01Z","timestamp":1787669221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-24-00097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":40,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-24-00097","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"2024-01-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}